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Pathogenic Escherichia coli strains commonly harbor genes involved in formation of ﬁmbriae, such as the
sfaII ﬁmbrial gene cluster found in uropathogenic and newborn meningitis isolates. The sfaXII gene,
located at the distal end of the sfaII operon, was recently shown to play a role in controlling virulence-
related gene expression in extraintestinal pathogenic E. coli (ExPEC). Until now, detailed characterization
of the SfaXII protein has been hampered by difﬁculties in obtaining large quantities of soluble protein. By
a rational modeling approach, we engineered a Cys70Ser mutation, which successfully improved solubil-
ity of the protein. Here, we present the expression, puriﬁcation, and initial characterization of the recom-
binant SfaXIIC70S mutant. The protein was produced in E. coli BL21 (DE3) cells grown in autoinduction
culture media. The plasmid vector harbored DNA encoding the SfaXIIC70S protein N-terminally fused with
a six histidine (H6) sequence followed by a ZZ tag (a derivative of the Staphylococcus protein A) (H6-ZZ
tag). The H6-ZZ tag was cleaved off with Tobacco Etch Virus (TEV) protease and the 166 amino acid
full-length homo-dimeric protein was puriﬁed using afﬁnity and size-exclusion chromatography. Electro-
phoretic mobility gel shift assays and atomic force microscopy demonstrated that the protein possesses
DNA-binding properties, suggesting that the transcriptional regulatory activity of SfaXII can be mediated
via direct binding to DNA.
 2012 Elsevier Inc. Open access under CC BY-NC-ND license.Introduction surface with an adhesin at the distal end that enable bacterialEscherichia coli (E. coli)2 is a commensal bacterium in the hu-
man intestinal microbiota, nevertheless several pathogenic vari-
ants exist that can cause various intestinal or extraintestinal
infections in man and animals. Extraintestinal pathogenic E. coli
(ExPEC) strains are a common cause of urinary tract infections
but can also be the causative agents of other human diseases, such
as meningitis, sepsis, pneumonia, and surgical site infections [1,2].
The ExPEC strains possess several virulence traits that facilitate
colonization, invasion and pathogenesis in speciﬁc bodily locations
[3]. The interaction of ExPEC with host cells is generally mediated
by ﬁmbriae, hair-like structures protruding from the bacterial cell. Uhlin).
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-NC-ND license.adhesion to different host receptors. The bacteria also often have
the ability to express different ﬁmbriae in an alternative manner
and in response to signals from the environment [4].
Proteins needed for production of different types of ﬁmbriae,
e.g., P ﬁmbriae, F1C ﬁmbriae, Type 1 and S ﬁmbriae, are encoded
by separate gene clusters, such as pap, foc, ﬁm and sfa, respectively.
Usually, these gene clusters, acquired by horizontal gene transfer
[5,6], consist of a set of genes for biogenesis of the actual ﬁmbriae
components-a chaperone, an usher, the ﬁmbrial subunits, and an
adhesin – as well as regulatory genes. Recent studies revealed a
regulatory network among ﬁmbrial adhesin gene systems in
ExPEC, which suggest that there may be a hierarchy in their
expression [7].
S-ﬁmbriae is predominantly expressed by newborn meningitis
E. coli (NMEC) isolates, which cause neonatal meningitis. However,
S-ﬁmbriae are also found in uropathogenic E. coli (UPEC) strains,
enabling the bacteria to bind to human bladder and kidney
epithelium [8]. The gene sfaXII, located immediately downstream
of the S-ﬁmbrial gene cluster sfaII, was ﬁrst characterized in the
NMEC isolate IHE3034 [9,10]. Genetic analyses have shown that
the SfaXII protein acts on the phase variation switch of the man-
nose-binding Type 1 ﬁmbriae, and that it has a regulatory role both
in ﬁmbrial expression and in ﬂagella expression [11].
Table 1
E. coli strains and plasmids used in this study.
Strain/
plasmid
Description/relevant characteristics Reference/
source
E. coli strains
DH5a F, recA1, endA1, hsdR17, supE44, thi-1, gyrA96,
relA1
Laboratory
stock
BL21(DE3) F ompT hsdSB(rB, mB) gal dcm (DE3) Novagen
IHE3034 NMEC clinical isolate, O18K1 :H7 [10]
AES4 IHE3034 DsfaXII [11]
Plasmids
pET28a(+) Expression vector with hexahistidine tag, Kanr Novagen
pBR322 Cloning vector, CbR, TcR [45]
pAES1 pBR322, sfaXII gene from sfaII operon [11]
pPPT1 pAES1 with the gene encoding for the mutated
protein SfaXIIC70S
This study
pETZZ_1a pET24d with the ZZ tag. Protein A binding
domain, double domain.
[29,46]
pPPT2 pETZZ_1a- sfaXIIC70S gene This study
pETGST_1a pET24d, glutathion-S-transferase [29,47]
pETMBP_1a pET24d, maltose binding protein [29,48]
pETTrx_1a pET24d, E. coli thioredoxin A [29,49]
pETNus_1a pET24d, N-Utilization substance [29,38]
pETGB1_1a pET24d, protein G binding domain [29,50]
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to the MarR family of transcriptional regulators, a protein family
involved in mechanisms such us the control of antibiotic resis-
tance, virulence factor production, as well as the response to oxida-
tive stress [12]. These proteins are found throughout the bacterial
and archaeal domains [13] and bind palindromic or pseudopalin-
dromic DNA as homodimers, resulting in either transcriptional
repression, activation or both [14]. Crystal structures have been
determined for several members of the MarR family, including
the structures of apoproteins [15] and proteins in complex with
cognate DNA [16,17]. The MarR family of proteins are alpha-helical
and interact with DNA via a conserved, winged, helix-turn-helix
motif [18].
SfaXII is also a member of a subfamily of 17-kDa proteins en-
coded by genes downstream of various ﬁmbrial operons, such as
pap, foc, prs and prf, in both UPEC and NMEC strains. In keeping
with the localization of these genes, the proteins have been named
PapX, FocX, PrsX and PrfX, respectively, after the corresponding
upstream operon [11,19]. The sequence identity between SfaXII
and these 17-kDa proteins varies between 87–96% [9,11]. A target
DNA sequence for the PapX protein was recently determined in the
ﬂhD regulatory region [20], but otherwise little is known about the
properties of this family of proteins. To begin characterizing the
biological function of this family of proteins, we have developed
an efﬁcient protocol for expression and puriﬁcation of recombinant
SfaXII from E. coli. In addition, we present here a molecular model
of the protein structure of SfaXII.Materials and methods
Protein sequence analysis and molecular modeling of SfaXII in silico
SfaXII was modeled in silico with the homology molecular
modeling program MODELLER 9v6 [21]. The software identiﬁed
the following set of four crystal structures as templates, allowing
optimal modeling of the SfaXII protein from residues 26 to 166:
PDB IDs: 2FBH (Pseudomonas aeruginosa transcriptional regulator
MarR family), 1JGS (E. coli multiple antibiotic-resistance protein
MarR), 2A61 (Thermotoga maritima transcriptional regulator
MarR family), 3BJA (Bacillus cereus putative MarR-like transcrip-
tion regulator). Their sequences were aligned using ClustalW
[22]. Five distinct models were generated, and their geometry
was assessed by a Ramachandran plot calculated with the pro-
gram RAMPAGE [23].
Calculation of root-mean-square deviation (RMSD) of Ca atoms
and superimposition of structures were performed with the pro-
gram DaliLite [24]. Figures of the structures were prepared with
the programs PyMOL [25] and ESPript [26]. Predictions of the sec-
ondary structure were made using Jpred software [27].
Bacterial strains, plasmids and growth conditions
The E. coli strains and plasmids used in the present work are de-
scribed in Table 1. Unless otherwise stated, the strains were grown
at 37 C in either Luria–Bertani (LB) broth or autoinduction med-
ium [28] with vigorous shaking as well as on tryptone yeast agar.
When necessary, antibiotics were added at the following concen-
trations: carbenicillin 50 lg/mL and kanamycin 50 lg/mL.
Cloning of the gene encoding SfaXII and generation of the SfaXIICys70
mutant
The sfaXII gene encoding the SfaXII protein was ampliﬁed by PCR
from genomic DNA of the extraintestinal pathogenic E. coli strain
IHE3034. NcoI and Acc65I restriction sites were introduced intothe oligonucleotide primers for the upstream and downstream
sequences. PCR was carried out with High Fidelity Pfu DNA poly-
merase under the following conditions: 3 min at 95 C and 40 cy-
cles of 30 s at 95 C, 30 s at 68 C and 1 min at 72 C, followed by
5 min at 72 C for ﬁnal elongation of the products. The PCR frag-
ment was digested with NcoI and Acc65I and subcloned into
pET24d vectors including a H6 tag combined with GST, MBP, thio-
redoxin, NusA, the Gb1-domain, and a double Z-domain (ZZ)
(kindly provided by Gunter Stier) as N-terminal fusions, respec-
tively [29]. Ligation was carried out with T4 DNA ligase (Promega)
overnight at 15 C.
Cysteine 70 was replaced by serine using the QuickChange 2
Site Directed Mutagenesis kit (Stratagene). The pETZ2_1a-SfaXII
template, a pET-based plasmid encoding the H6-ZZ-SfaXII protein,
was denatured at 95 C. The primers for mutagenesis (containing
the desired mutation) were annealed at 55 C and extended using
PfuUltra DNA polymerase at 68 C. The parental DNA was digested
with the restriction endonuclease DpnI. Puriﬁed mutant DNA
(pPPT2) was introduced by transformation into competent cells
and subsequently the plasmid clone with the sfaXIIC70S allele was
harvested. The sequences of both the native parental and mutated
genes were conﬁrmed by DNA sequencing. For the in vivo analysis,
the plasmid pAES1 was used as template and following the same
protocol as above, we generated the plasmid pPPT1 (pAES1-
sfaXIIC70S). Likewise, the mutation was conﬁrmed by DNA sequence
analysis.
Western blot analysis
3.5 mL of bacteria with an OD600 of 2.0 were pelleted by
centrifugation and resuspended in sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE) sample buffer.
Identical amounts were subsequently subjected to SDS–PAGE
(15% polyacrylamide concentration) and thereafter transferred
to a polyvinylidene ﬂuoride (PVDF) micro-porus membrane. To
detect expression of SfaXII and SfaXIIc70S proteins, polyclonal
rabbit antiserum obtained by immunization with gel puriﬁed
protein was used as primary antibody. Further visualization
was carried out using the ECL+ method described by the manu-
facturer (Amersham Biosciences). Detection of bands was per-
formed using the Fujiﬁlm LAS4000 system exposing the
chemiluminescent membrane.
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Overnight cultures were diluted in LB and adjusted to an OD600
of 1.0. A drop (5 lL) was put on semi-solid plates containing 0.3%
agar and incubated at 37 C to compare the diameter of the area
of spreading bacteria.
Overproduction and puriﬁcation of the mutant SfaXIIC70S
E. coli BL21 (DE3) bacteria transformed by electroporation with
the pPPT2 plasmid (pETZZ_1a- sfaXIIC70S) were grown overnight at
37 C in Luria–Bertani (LB) medium containing 50 lg/mL kanamy-
cin. The overnight culture was used to inoculate (20 mL/L) 4 L of
autoinduction medium [28] (containing 50 lg/mL kanamycin)
and incubated for 12 h at 30 C with shaking. Cells were harvested
by centrifugation at 4000g for 10 min. The bacterial pellet (usually
10 g) was resuspended in sodium phosphate buffer pH 7.4
(136 mM NaCl, 2.6 mM KCl, 10.2 mM Na2HPO4, 1.7 mM KH2PO4),
23 mM ammonium sulfate, 300 mM NaCl (buffer A), in the pres-
ence of 1 mM protease inhibitor phenylmethanesulfonylﬂuoride
(PMSF) and 1 mM dithiothreitol (DTT). Cells were disrupted by
sonication (20 min, 30% of amplitude, 5 s ON, 5 s OFF). The lysate
was cleared by centrifugation (12000g, 1 h at 4 C). The superna-
tant containing the soluble H6-ZZ tagged protein was ﬁltered
through a 0.22-lm pore ﬁlter and loaded onto a column containing
Ni–NTA resin (Qiagen). The lysate/Ni–NTA-agarose mixture was
washed eight times with a total of 40 mL of buffer A containing
10 mM imidazole. Protein elution was carried out with ten por-
tions (5 mL) buffer A containing 200 mM imidazole. The eluted
fractions were collected and analyzed by SDS–PAGE. The fractions
containing the protein were collected and dialyzed overnight
against buffer A. Protein concentration was determined by measur-
ing the absorbance at 280 nm (A280) using a theoretical extinction
coefﬁcient of 18.910 M1 cm1. To prepare the untagged protein,
the H6-ZZ tag was cleaved off by digestion with H6-AcTEV [30],
an enhanced form of Tobacco Etch Virus (TEV) protease (kindly
provided by Gunter Stier and Christin Grundström), using 1 unit
of enzyme per 3 lg of H6-ZZ-SfaXIIC70S at 4 C overnight. Digestion
was done in buffer A with 1 mM DTT and 0.5 mM EDTA in order to
enhance the proteolytic efﬁciency. Digested samples were loaded
onto a column containing the resin IgG Sepharose 6 fast ﬂow (GE
Healthcare), which binds protein A fusion conjugates. H6-ZZ and
undigested protein were bound to the resin and ﬂow-through, con-
taining the native protein, was collected. H6-AcTEV protease, also
present in the ﬂow-through, was removed by passing the ﬂow-
through over a Ni-agarose resin, which retained the protease.
Finally, SfaXIIC70S was subjected to size-exclusion chromatography
with an ÄKTA puriﬁer (GE Healthcare) and a HiLoad 16/60 super-
dex 75 prep grade column equilibrated with buffer A. Elution
corresponded to a 40-kDa protein indicating a dimeric form of
the protein in solution. Calculating protein concentration with a
theoretical extinction coefﬁcient of 14.440 M1cm1, SfaXIIC70S
was concentrated to 4 mg/mL using a 10-kDa molecular-mass
cutoff membrane (Vivascience) and stored at 4 C.
Circular dichroism spectroscopy
Far-UV circular-dichroism (CD) spectra were collected on sam-
ples containing 10 lM SfaXIIC70S in sodium phosphate buffer pH
7.4, 300 mM NaCl, and 23 mM ammonium sulfate using a JASCO
J-810 spectropolarimeter and 1-mm quartz cuvettes. Spectra were
recorded between 196 and 260 nm, averaged over ﬁve scans, with
a bandwidth of 2 nm, a response time of 2 s, a pitch of 0.5 nm and a
scan rate of 20 nm/min. Thermal unfolding and refolding of the
protein was investigated by monitoring the ellipticity at 220 nm
in the temperature interval 4–80 C, using a temperature gradientof 1 C/min. The melting temperature was determined from the
inﬂection point of the transition. Evaluation of the secondary struc-
ture content of the protein was carried out by using the CDNN pro-
gram [31].
Electrophoretic mobility shift assays
Electrophoretic mobility shift assays [32] were performed with
the puriﬁed mutant SfaXIIC70S using a gradient of protein concen-
tration from 0.4 to 2 lM, and 125 ng DNA representing 300 bp
from the regulatory region of the sfa operon in each test of 10 lL
(DNA concentration was determined using the NanoDrop system).
Binding was allowed to occur at 37 C in a buffer containing 25 mM
Hepes pH 7.5, 100 mMKCl, 0.1 mM EDTA, 5 mMDTT, and 10% glyc-
erol. After 15 min of incubation, aliquots of the assay mixture were
mixed with loading solution and run on a 6% w/v polyacrylamide
native gel at 12 mA for 1 h. Staining with ethidium bromide was
sufﬁciently sensitive to visualize the DNA fragments.
Atomic force microscopy
DNA–protein complexes were diluted with ultrapure water
(Millipore) and immediately placed on a freshly cleaved mica sur-
face as described previously [33]. The samples were incubated at
37 C for 5 min, gently washed with ultrapure water, and dried in
a desiccator for at least 2 h. Imaging was performed on a Nano-
scope V Atomic Force Microscope (Bruker) using Tapping mode.
The images are presented in amplitude mode.Results and discussion
We have characterized the transcriptional regulator SfaXII
encoded within the sfa gene cluster in E. coli strains that cause
newborn meningitis and uropathogenic diseases. SfaXII shows
weak sequence similarity to the MarR family of transcriptional reg-
ulators and is a member of a 17-kDa protein family whose genes
are located at the distal end of the sfa, pap, foc, prs and prf ﬁmbrial
gene clusters. The proteins in this family, SfaX, PapX, FocX PrsX and
PrfX, have highly conserved primary amino acid sequences (>90%),
but their structures have not yet been determined experimentally.
Nevertheless, predicted secondary structures suggest that, despite
low sequence identity (<20%), the proteins share structural fea-
tures with the MarR family. Fig. 1 shows the predicted secondary
structural motifs of SfaXII and MarR proteins whose structures
have been determined. Overall, the distributions of helices and
strands in SfaXII are predicted to be close to identical to those
of the MarR proteins, with the exception of an N-terminal 26-
amino-acid insertion in the SfaXII protein predicted to form an
extra alpha-helix (a1). Using the program MODELLER and four
previously determined structures of MarR representatives as
templates (Figs. 1 and 2A), we built ﬁve molecular models of SfaXII.
Stereochemically, the quality of the polypeptide backbone and side
chains of the modeled structures was assessed using Ramachan-
dran plots obtained from the RAMPAGE server. The model with
the most stable structure (Fig. 2B) had 133 residues (95.7%) in
the most favored regions; four (2.9%) residues in additionally
allowed regions and two (1.4%) residues in disallowed regions.
Pairwise superimpositions of the SfaXII model with those of the
MarR reference proteins yield average root-mean-square devia-
tions (RMSD) of 2 Å for 140 equivalent Ca positions in residues
26–166 of SfaXII.
Initial attempts to purify SfaXII overexpressed in bacteria were
unsuccessful due to insolubility of the protein. In order to increase
solubility, we therefore turned to site-directed mutagenesis. SfaXII
contains two cysteine residues at positions 32 and 70 that could
Fig. 1. Multiple sequence alignment of SfaXII with proteins of the MarR family identiﬁed by BLAST analysis. The amino acid sequences of SfaXII and transcriptional regulators
of the MarR family with code PDB 2FBH , 1JGS, 2A61 and 3BJA for Pseudomonas aeruginosa, Escherichia coli, Thermotoga maritima and Bacillus cereus, respectively, were aligned
using ClustalW. Identical residues are depicted in white on a red background; similar residues are shown in red type in an open box. The ﬁgure was drawn with ESPript and
the secondary structure for each of the crystallized proteins is shown above the sequences, with arrows for beta-strands and ribbons for alpha-helices. Jpred software was
employed for secondary structure prediction (H, a-helices and E, b-strands) of the protein SfaXII. (For interpretation of the references to color in this ﬁgure legend, the reader
is referred to the web version of this article.)
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From analyses of the model structure and the monomer–monomer
interface in the biological dimer of the MarR proteins, we located
the positions of the two cysteine residues within the presumed
biological dimer of SfaXII (Fig. 2C). Cys70 is located at the surface
of the structure and not in the vicinity of the helix-turn-helix
DNA-binding motif. In contrast, the model suggested that Cys32
is involved in the formation of dimers. Based on this data, we
therefore decided to mutate only the Cys70 residue to serine.
In order to analyze whether the C70S substitution would affect
the phenotype of strains expressing SfaXIIC70S, we mutated the
sfaXII gene contained in the plasmid pAES1 by site-directed muta-
genesis. We transformed with this plasmid the extraintestinal
pathogenic E. coli strain IHE3034 as well as the SfaXII-deﬁcient
IHE3034 derivative (strain AES4) and performed tests similar to
earlier published studies with the pAES1 clone [11]. Fig. 3A shows
the expression levels of SfaXII and SfaXIIC70S in cells at the OD600 of
2.0. Strain ‘‘b’’ (IHE3034 transformed with the vector control
pBR322) did not express a detectable level of SfaXII. By contrast,
with the strains transformed with the plasmids pAES1 or pPPT1
we could readily detect the SfaXII and SfaXIIC70S protein expression.
Moreover, these two proteins were expressed at equal levels and
their functionality was analyzed by bacteria motility assays. In
studies of the effect of the SfaXII protein on ﬂagella expression it
was previously reported that SfaXII represses the ﬂagella expres-
sion and therefore bacterial motility [11]. Fig. 3B shows the motil-
ity of the different (a–e) strains 5 h after inoculation. In correlation
with western blot results, strains with low level or lacking SfaXII (band c) were more motile. Furthermore, strains which expressed
SfaXII (a and d) or SfaXIIC70S (e) at equal levels showed similarly
reduced motility. Strain ‘‘e’’ showed the same phenotype as ‘‘d’’
and thus we can conclude that the substitution C70S is not
affecting this in vivo regulatory property of the protein.
To further improve solubility, we tested co-expression of the
protein with several carrier proteins. These carrier proteins are
known to inﬂuence the expression, solubility and stability of target
proteins because of their unique folding properties and high solu-
bility [34]. For ease of puriﬁcation, we used pET vectors with an H6
tag (six histidine) bound to the carrier proteins: glutathione-S-
transferase (GST) [35], the maltose-binding protein (MBP) [36], thi-
oredoxin [37], NusA [38,39], the Gb1-domain from protein G (Gb1)
[40], and a double Z-domain from protein A (ZZ) [41]. All carrier
proteins were fused to the N-terminal end of the SfaXIIC70S protein.
From co-expression tests of the SfaXIIC70S protein with the var-
ious carrier proteins [42], the best overexpression and solubility
was obtained using the H6-ZZ-SfaXIIC70S construct. ZZ is a repeti-
tion of the ‘‘Z’’ domain based on the ‘‘B’’ IgG binding domain of pro-
tein A from Staphylococcus aureus and this domain can be easily
puriﬁed using an IgG Sepharose™ 6 Fast Flow column to which
the ‘‘ZZ’’ domain binds tightly [43]. This feature was used as an
advantage to separate SfaXIIC70S after digestion from the H6-ZZ
tag as well as from undigested protein.
To overexpress the protein, we initially used the conventional
method with Luria–Bertani (LB) medium and the addition of iso-
propyl-b-D-thiogalactopyranoside (IPTG) at the logarithmic phase.
Many attempts were made, with changes to several different
Fig. 2. Structural model of the protein SfaXII from Escherichia coli strain IHE3034.
(A) Superimposition made with the program DaliLite of the four structures used as
templates for molecular modeling of SfaXII (PDB codes: 1JGS, 2FBH, 2A61, 3BJA). (B)
Cartoon representation of the structural model of SfaXII (residues 26–166). (C)
Cartoon representation showing the model of the SfaXII dimer. The monomers are
shown in blue and grey, respectively. The interface is modeled from the Escherichia
coli MarR structure (PDB code 1JGS). The side chains of Cys32 and Cys70 are shown
as sticks in red and yellow, respectively. Cys 32 in the two monomers are in close
contact across the dimer interface and could be involved in an inter-subunit
disulﬁde bridge. Cys70 residues, on the other hand, are situated at the surface of the
complex. (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article.)
A
B
Fig. 3. Phenotypic tests of strains expressing the SfaXIIC70S protein. (A) Western blot
analysis of SfaXII and SfaXIIC70S expression level. Lane1, molecular mass marker;
Lane 2, pure SfaXIIC70S, control; Lane 3, IHE3034/pAES1 ‘‘a’’; Lane 4, IHE3034/
pBR322 ‘‘b’’; Lane 5, AES4/pBR322 ‘‘c’’; Lane 6, AES4/pAES1 ‘‘d’’; Lane 7, AES4/pPPT1
‘‘e’’. Bacteria were grown in LB at 37 C to early stationary phase and samples were
prepared to examine levels of proteins. (B) Analysis of motility of strains ‘‘a, b, c, d
and e’’ corresponding to IHE3034/pAES1, IHE3034/pBR322, AES4/pBR322, AES4/
pAES1 and AES4/pPPT1 respectively. Strains were growing on plates containing
0.3% agar at 37 C.
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sufﬁcient amounts of homogeneous and pure protein. The use of an
autoinduction medium did not change the expression level of the
protein, although it did signiﬁcantly improve the solubility
[28,44]. The advantage of this medium is that it induces automatic
and gradual protein expression, unlike the traditional method of
adding IPTG. In the autoinduction medium, stringent control ofthe promoter in the early phase of growth occurs via catabolite
repression by glucose. Glycerol and lactose are used as additional
carbon sources and Plac-controlled protein production is induced
when the bacterial cells have consumed the glucose. In addition,
this medium contains 23 mM of ammonium sulfate, which gener-
ally helps promote solubilization of DNA-binding proteins. After
cleavage of H6-ZZ with the TEV protease (Fig. 4A), gel ﬁltration
of SfaXIIC70S yielded a peak corresponding to the size of the dimeric
protein (Fig. 4B). Protein purity was veriﬁed by SDS–PAGE (Fig. 4C).
Typically, we obtain 10 mg of pure protein from expression in
four liters of autoinduction media.
In order to investigate the structural properties of theprotein and
its thermostability, we recorded far-UV circular-dichroism spectra.
The observed spectrum (Fig. 5A) is characteristic of a protein with
a signiﬁcant fraction of a-helical secondary structure; by using the
program CDNN, the secondary structure content was estimated to
be 37% a-helix, 15% b-strand, 16% b-turn and 29% random coil. The
thermal unfolding and refolding experiments (Fig. 5B) show that
the protein unfolds irreversibly into an aggregation-prone random
coil/b-sheet conformation, with a melting point of 51 C.
We also investigated the DNA-binding properties of the
SfaXIIC70S protein. Electrophoretic mobility shift assays conﬁrmed
DNA binding to the 300-bp fragment of the sfa operon regulatory
region. We have not characterized in detail the binding speciﬁcity
of SfaXIIC70S (Fig. 6A), however the mobility shift results are
Fig. 4. Analysis of puriﬁed SfaXIIC70S preparations. (A) SDS–PAGE showing samples obtained after TEV digestion. Lane 1, molecular mass markers; Lane 2, TEV protease; Lane
3, partial digestion of H6-ZZ-SfaXIIC70S by TEV protease in buffer A; Lane 4, protein sample after ON cleavage with TEV protease in buffer A containing 1 mM DTT and 0.5 mM
EDTA. (B) FPLC gel ﬁltration on HiLoad 16/60 Superdex 75 prep grade column. Sample: SfaXIIC70S. Buffer: Sodium phosphate buffer (pH 7.4), 300 mM NaCl, 23 mM ammonium
sulfate. Fraction size: 1 mL. Flow rate: 1 mL/min. (C) SDS–PAGE analysis of the ﬁnal puriﬁcation stage of SfaXIIC70S. Fractions were analyzed by 15% SDS–PAGE and stained
with Coomassie Blue.
Fig. 5. Circular Dichroism. (A) Far-UV CD spectrum of a sample containing 10 lM
SfaXIIIIC70S. The spectrum was analyzed using the CDNN program [31] to give
estimates of 37% a-helix, 15% b-sheet, 16% b-turn and 29% random coil. (B) Thermal
unfolding (solid line) and refolding (dashed line) of the protein was investigated by
monitoring the ellipticity at 220 nm in a temperature range of 4–80 C.
Fig. 6. In vitro DNA binding analyses with SfaXIIC70S. (A) Gel mobility shift assays
with a gradient of puriﬁed SfaXIIC70S protein from 0.4 to 2 lM with a 300-bp
fragment of DNA from the sfa operon. Lane 1 is the negative control containing only
DNA. (B) Representative atomic force micrographs of the 300-bp fragment of DNA
from the sfa operon. (C) Atomic force micrographs showing the binding of SfaXIIC70S
to the DNA fragment. The area of DNA that was bound by the SfaXIIC70S protein is
indicated by arrows. SfaXIIS70S (0.8 lM) was incubated with 50 ng of DNA on the
mica at 37 C.
132 P. Paracuellos et al. / Protein Expression and Puriﬁcation 86 (2012) 127–134consistent with ﬁndings from single-molecule analysis by atomic
force microscopy. Compared to images of the mica surface with
only DNA (Fig. 6B) we see that, after incubation with SfaXIIC70S,
the DNA was partially bound by the protein (ﬁgure 6C).
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In this study, we created a site-directed mutant of SfaXII, a tran-
scriptional regulator involved in ExPEC ﬁmbriae formation, and
developed an efﬁcient protocol for expression and puriﬁcation of
the recombinant protein. Insolubility of the native protein
prompted us to analyze a molecular model of SfaXII, which sug-
gested that a Cys70Ser substitution could improve protein solubil-
ity and in vivo studies indicated that this substitution is not
affecting the SfaXII regulatory function within the cell. In agree-
ment with this, the SfaXIIC70S mutant showed a ﬁvefold increase
in solubility, presumably by avoiding non-native intermolecular
disulﬁde bonds. Autoinduction medium as an alternative to stan-
dard induction by addition of IPTG, combined with an H6-ZZ car-
rier fused to the N-terminal end of the protein, gave us a high
yield of soluble protein: four liters of autoinduction media typi-
cally yielded 10 mg of pure protein.
The structural properties and thermostability of puriﬁed
SfaXIIC70S were determined by far-UV CD spectroscopy and showed
that the protein has a predominant a-helical secondary structure,
in agreement with our molecular model, and a melting tempera-
ture of 51 C. Gel shift electrophoretic mobility assays as well as
atomic force microscopy showed that the protein binds DNA at
the regulatory region of the sfa operon.
The approach described herein might be applicable to most
members of the family of 17-kDa proteins whose genes are associ-
ated with ﬁmbriae operons (e.g., PapX, FocX, PrsX and PrfX pro-
teins) due to their highly conserved sequences. In summary, this
robust protocol for expression and puriﬁcation of SfaXIIC70S, as well
as our molecular model, open new perspectives and possibilities to
better understand the functionality and speciﬁcity in terms of pro-
tein–DNA interactions of this family of proteins whose genes and
localization near operons involved in ﬁmbriae expression are
highly conserved in ExPEC.Acknowledgments
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